Fluoroquinolone-resistant Escherichia coli, Indonesia

Emerging Infectious Diseases

Volumn 11, Issue 9, 2005, Pages 1363-1369

  Kuntaman, Kuntaman ^a   Lestari, Endang Sri ^b   Severin, Juliëtte A ^c   Kershof, Irma M ^c   Mertaniasih, Ni Made ^a   Purwanta, Marijam ^a   Hadi, Usman ^a   Johnson, James R ^d   Van Belkum, Alex ^c   Verbrugh, Henri A ^c  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b DIPONEGORO UNIVERSITY   (Indonesia)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CLONAL VARIATION; ESCHERICHIA COLI; FECES MICROFLORA; GENETIC VARIABILITY; HEALTH CENTER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INDONESIA; MOLECULAR TYPING; NONHUMAN; PHYLOGENY; PREVALENCE;

EID: 23944456330     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1109.041207     Document Type: Article

References (21)

1. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis. 2001;183:78-88.
2. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol. 1990;172:6175-81.
3. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999;67:546-53.
4. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis. 2003;188:759-68.
5. Russo TA, Johnson JR. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis. 2000;181:1753-4.
6. Chaniotaki S, Giakouppi P, Tzouvelekis LS, Panagiotakos D, Kozanitou M, Petrikkos G, et al. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. Clin Microbiol Infect. 2004;10:75-8.
7. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 1999;43:2736-41.
8. Van Belkum A, Goessens W, Van der Schee C, Lemmens-den Toom N, Vos MC, Cornelissen J, et al. Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis. 2001;7:862-71.
9. Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 2003;47:3222-32.
10. Johnson JR, Van der Schee C, Kuskowski MA, Goessens W, Van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis. 2002;186:1852-6.
11. McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, Huang CH, et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother. 2001;45: 3084-91.
12. Van Belkum A, Van Leeuwen W, Kluytmans J, Verbrugh H. Molecular nosocomial epidemiology: high speed typing of microbial pathogens by arbitrary primed polymerase chain reaction assays. Infect Control Hosp Epidemiol. 1995;16:658-66.
13. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19:6823-31.
14. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555-8.
15. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181:261-72.
16. Luria SE, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 1943;28:491-511.
17. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47:2242-8.
18. Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventre A, Elion J, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology. 2001;147:1671-6.
19. Zhang L, Foxman B, Marrs C. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol. 2002;40:3951-5.
20. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia versus uninfected control patients. J Infect Dis. 2004;190:2121-8.
21. Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D, Catal C, Ang-Kucuker M, Ang O. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect. 2004;10:72-5.